Mark D. Pearlman, MD

Article

2023 USPSTF mammography age to start screening in average-risk patients: What’s new is old again

Author:: Mark D. Pearlman, MD

Publish date: November 27, 2023

Article

Does tamoxifen use increase the risk of endometrial cancer in premenopausal patients?

Author:: Mark D. Pearlman, MD

Publish date: August 9, 2023

In a large, nationwide retrospective longitudinal cohort study that examined the occurrence of endometrial cancer and other uterine pathology in pa...

Article

Progress in breast cancer screening over the past 50 years: A remarkable story, but still work to do

Author:: Mark D. Pearlman, MD

Publish date: February 19, 2023

Expert perspective on the myriad factors that play a role in breast cancer screening recommendations and the guidelines to consider when engaging p...

Article

Late-onset recurrence in breast cancer: Implications for women’s health clinicians in survivorship care

Author:: Mark D. Pearlman, MD

Publish date: February 15, 2022

Data show that late-onset recurrence is more likely among patients with an initial tumor size >2 cm, lymph node–positive disease, and hormone re...

Article

It’s not time to abandon routine screening mammography in average-risk women in their 40s

Author:: Mark D. Pearlman, MD

Publish date: October 20, 2020

Results of a new mammography screening study inform us that routine breast cancer risk assessment to facilitate patie...

Article

Should supplemental MRI be used in otherwise average-risk women with extremely dense breasts?

Author:: Mark D. Pearlman, MD

Publish date: February 6, 2020

Recent data show that supplemental MRI screening in women with extremely dense breasts and negative screening mammograms decreases the rate of inte...

Article

Should breast cancer screening guidelines be tailored to a patient’s race and ethnicity?

Author:: Mark D. Pearlman, MD

Publish date: May 31, 2018

Yes. Because women of minor ity races/ethnicities have an earlier age of onset of breast cancer (45 to 50 years) compared with whi...

Article

How does oral contraceptive use affect one’s risk of ovarian, endometrial, breast, and colorectal cancers?

Author:: Mark D. Pearlman, MD

Publish date: April 26, 2018

Oral contraceptives (OCs) are associated with a decreased risk of ovarian and endometrial cancers across multiple modifiable lifes...

Article

Does hormonal contraception increase the risk of breast cancer?

Author:: Mark D. Pearlman, MD

Publish date: January 30, 2018

These experts analyze the data from a recent large study and provide counseling points for your patients

Article

Breast cancer screening: Is the controversy of benefits versus harms resolved?

Author:: Mark D. Pearlman, MD

Publish date: October 30, 2017

Researchers recently described which national mammography screening strategy most effectively reduced breast cancer mortality and resulted in most ...

Article

Does extending aromatase-inhibitor use from 5 to 10 years benefit menopausal women with hormone-positive breast cancer?

Author:: Mark D. Pearlman, MD

Publish date: August 2, 2016

In terms of improving the 5-year disease-free survival (DFS) rate, yes, according to results of a randomized study that compared extended letrozole...